Gastric peptides and their regulation of hunger and satiety

Current Gastroenterology Reports

Volumn 14, Issue 6, 2012, Pages 480-488

  Stengel, Andreas ^a   Taché, Yvette ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Brain gut axis; Desacyl ghrelin; Food intake; Ghrelin; Nesfatin 1; NUCB2; Obesity; Obestatin; X A like cell

Indexed keywords

ACYLTRANSFERASE; DESACYL GHRELIN; GASTRIC PEPTIDE; GHRELIN; GHRELIN O ACYLTRANSFERASE; GHRELIN RECEPTOR; NESFATIN 1; OBESTATIN; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; ENDOCRINE CELL; ENERGY BALANCE; ENTEROENDOCRINE CELL; FEEDING BEHAVIOR; FOOD INTAKE; HORMONE ACTION; HORMONE RELEASE; HUMAN; HUNGER; NONHUMAN; NUCB2 GENE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; REGULATORY MECHANISM; SATIETY; SIGNAL TRANSDUCTION; SMALL INTESTINE;

ANIMALS; BRAIN; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; EATING; GHRELIN; HUMANS; HUNGER; NERVE TISSUE PROTEINS; PARIETAL CELLS, GASTRIC; PEPTIDE HORMONES; SATIETY RESPONSE; STOMACH;

EID: 84870567025     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0291-3     Document Type: Article

References (121)

1. Rindi G, Leiter AB, Kopin AS, et al. The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann N YAcad Sci. 2004;1014:1-12
2. Hameed S, Dhillo WS, Bloom SR. Gut hormones and appetite control. Oral Dis. 2009;15:18-26
3. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growthhormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60
4. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255-61
5. Hiejima H, Nishi Y, Hosoda H, et al. Regional distribution and the dynamics of n-decanoyl ghrelin, another acyl-form of ghrelin, upon fasting in rodents. Regul Pept. 2009;156:47-56
6. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005;310:996-9
7. Stengel A, Goebel M, Yakubov I, et al. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology. 2009;150:232-8
8. Inhoff T, Wiedenmann B, Klapp BF, et al. Is desacyl ghrelin a modulator of food intake? Peptides. 2009;30:991-4
9. Stengel A, Taché Y. Minireview: Nesfatin-1-An emerging new player in the brain-gut, endocrine, and metabolic axis. Endocrinology. 2011;152:4033-8
10. Lacquaniti A, Donato V, Chirico V, et al. Obestatin: an interesting but controversial gut hormone. Ann Nutr Metab. 2011;59:193-9
11. KojimaM, Kangawa K. The discovery of ghrelin: with a little luck and great passion. Preface. Peptides. 2011;32:2153-4. This article provides insight to historical steps that led to the discovery of ghrelin retraced by Kojima and Kangawa in a very personal way
12. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522
13. Davenport AP, Bonner TI, Foord SM, et al. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev. 2005;57:541-6
14. Bednarek MA, Feighner SD, Pong SS, et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem. 2000;43:4370-6
15. Hosoda H, KojimaM, MatsuoH, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279:909-13
16. Raff H. Total and active ghrelin in developing rats during hypoxia. Endocrine. 2003;21:159-61
17. Stengel A, Keire D, Goebel M, et al. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology. 2009;150:5113-8. This article addresses a very relevant component of gut peptide determination: how blood processing after collection impacts on the concentrations and molecular forms of gut peptides detected after release (acyl vs. desacyl ghelin, PYY vs. PYY 3-36, CCK-8 vs. CCK-58)
18. Yang J, Brown MS, Liang G, et al. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132:387-96
19. Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A. 2008;105:6320-5
20. Sakata I, Yang J, Lee CE, et al. Colocalization of ghrelin Oacyltransferase and ghrelin in gastric mucosal cells. Am J Physiol Endocrinol Metab. 2009;297:E134-41
21. Stengel A, Goebel M, Wang L, et al. Differential distribution of ghrelin-O-acyltransferase (GOAT) immunoreactive cells in the mouse and rat gastric oxyntic mucosa. Biochem Biophys Res Commun. 2010;392:67-71
22. Lim CT, Kola B, Grossman A, Korbonits M. The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J. 2011;58:707-10
23. Kang K, Schmahl J, Lee JM, et al. Mouse ghrelin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption. FASEB J. 2012;26:259-71
24. Zhao CM, Furnes MW, Stenstrom B, et al. Characterization of obestatin-and ghrelin-producing cells in the gastrointestinal tractand pancreas of rats: an immunohistochemical and electronmicroscopic study. Cell Tissue Res. 2008;331:575-87
25. Gronberg M, Tsolakis AV, Magnusson L, et al. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem. 2008;56:793-801
26. Tsolakis AV, Grimelius L, Stridsberg M, et al. Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach. Eur J Endocrinol. 2009;160:941-9
27. Soares JB, Leite-Moreira AF. Ghrelin, des-acyl Ghrelin and obestatin: three pieces of the same puzzle. Peptides. 2008;29:1255-70
28. Oh-I S, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709-12
29. Brailoiu GC, Dun SL, Brailoiu E, et al. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology. 2007;148:5088-94
30. Foo K, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008;156:563-79
31. Kohno D, Nakata M, Maejima Y, et al. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology. 2008;149:1295-301
32. Osaki A, Shimizu H, Ishizuka N, et al. Enhanced expression of nesfatin/nucleobindin-2 in white adipose tissue of ventromedial hypothalamus-lesioned rats. Neurosci Lett. 2012;521:46-51
33. Shimizu H, Oh IS, Okada S, Mori M. Nesfatin-1: an overview and future clinical application. Endocr J. 2009;56:537-43
34. Kerbel B, Unniappan S. Nesfatin-1 suppresses energy intake, colocalises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish. J Neuroendocrinol. 2012;24:366-77
35. Jeon TY, Lee S, Kim HH, et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab. 2004;89:5392-6
36. Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002;51:124-9
37. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988
38. Barreiro ML, Gaytan F, Caminos JE, et al. Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol Reprod. 2002;67:1768-76
39. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-9
40. Tschöp M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest. 2001;24: RC19-21
41. Schussler P, Kluge M, Yassouridis A, et al. Ghrelin levels increase after pictures showing food. Obesity (Silver Spring). 2012;20:1212-7
42. Xu G, Li Y, An W, et al. Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology. 2009;150:3637-44. This is the first demonstration of the reciprocal relationship between gastric mTOR signaling and ghrelin during changes in energy status which provides a link between the gastric fuel sensor and the impact on energy intake through ghrelin release
43. Toshinai K, Mondal MS, Nakazato M, et al. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun. 2001;281:1220-5
44. Kim MS, Yoon CY, Park KH, et al. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport. 2003;14:1317-20
45. Gonzalez CR, Vazquez MJ, Lopez M, Dieguez C. Influence of chronic undernutrition and leptin on GOAT mRNA levels in rat stomach mucosa. J Mol Endocrinol. 2008;41:415-21
46. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-13
47. Cummings DE,Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-30
48. Tschöp M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-9
49. Mizutani M, Atsuchi K, Asakawa A, et al. Localization of acyl ghrelin-and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol. 2009;297:G974-80
50. Stengel A, Goebel-Stengel M, Wang L, et al. Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2. Am J Physiol Gastrointest Liver Physiol. 2011;301:G239-48
51. Stengel A, Goebel M, Wang L, et al. Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: Potential role of the circulating ghrelin-acylating enzyme GOAT. Peptides. 2010;31:1689-96
52. Saidpour A, Zahediasl S, Kimiagar M, et al. Fish oil and olive oil can modify insulin resistance and plasma desacyl-ghrelin in rats. J Res Med Sci. 2011;16:862-71
53. Iwakura H, Li Y, Ariyasu H, et al. Establishment of a novel ghrelin-producing cell line. Endocrinology. 2010;151:2940-5
54. Iwakura H, Ariyasu H, Hosoda H, et al. Oxytocin and dopamine stimulate ghrelin secretion by the ghrelin-producing cell line, MGN3-1 in vitro. Endocrinology. 2011;152:2619-25
55. Wang L, Murphy NP, Stengel A, et al. Ghrelin prevents levodopainduced inhibition of gastric emptying and increases circulating levodopa in fasted rats. NeurogastroenterolMotil. 2012;24:e235-45
56. de la Cour CD, Norlen P, Hakanson R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regul Pept. 2007;143:118-26
57. Lu X, Zhao X, Feng J, et al. Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid (LCFA) through GPR 120 in isolated gastric ghrelin cells and mice. Am J Physiol Gastrointest Liver Physiol. 2012;303:G367-76. This is one of the first generations of transgenic mice with green fluorescent protein (GFP) expressing ghrelin cells enabling to show the regulation of ghrelin release by long chain free fatty acids in a pure population of isolated gastric ghrelin expressing GFP cells
58. Hattori N, Saito T, Yagyu T, et al. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab. 2001;86:4284-91
59. Schellekens H, Dinan TG, Cryan JF. Lean mean fat reducing "Ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology. 2010;58:2-16
60. Xu L, Depoortere I, Tomasetto C, et al. Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept. 2005;124:119-25
61. Camina JP, Carreira MC, El Messari S, et al. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology. 2004;145:930-40
62. Holst B, Cygankiewicz A, Jensen TH, et al. High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol Endocrinol. 2003;17:2201-10
63. Chollet C, Bergmann R, Pietzsch J, Beck-Sickinger AG. Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging. Bioconjug Chem. 2012;23:771-84. The authors discuss that the discoverey of novel ghrelin inverse agonists with featured of high stability in blood, slow blood clearance and large diffusion in tissues may be a promising approach to reduce ghrelin and ghrelin receptor signaling
64. Gauna C, Delhanty PJ, van Aken MO, et al. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol. 2006;251:103-11
65. Cassoni P, Papotti M, Ghe C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab. 2001;86:1738-45
66. Gourcerol G, Taché Y. Obestatin-A ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil. 2007;19:161-5
67. Zhang JV, Jahr H, Luo CW, et al. Obestatin induction of earlyresponse gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol. 2008;22:1464-75
68. Lauwers E, Landuyt B, Arckens L, et al. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun. 2006;351:21-5
69. Tremblay F, Perreault M, Klaman LD, et al. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology. 2007;148:501-6
70. Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology. 2007;148:13-20
71. Chartrel N, Alvear-Perez R, Leprince J, et al. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science. 2007;315:766. author reply 766
72. Li Z, Xu G, Li Y, et al. mTOR-dependent modulation of gastric nesfatin-1/NUCB2. Cell Physiol Biochem. 2012;29:493-500
73. Tsuchiya T, Shimizu H, Yamada M, et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf). 2010;73:484-90
74. Li QC, Wang HY, Chen X, et al. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept. 2010;159:72-7
75. Ogiso K, Asakawa A, Amitani H, et al. Plasma nesfatin-1 concentrations in restricting-Type anorexia nervosa. Peptides. 2010;32:150-3
76. Ramanjaneya M, Chen J, Brown JE, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depotspecific adipokine with increased levels in obesity. Endocrinology. 2010;151:3169-80
77. Tan BK, Hallschmid M, Kern W, et al. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/ NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab. 2011;96:E669-73
78. Garcia-Galiano D, Navarro VM, Gaytan F, Tena-Sempere M. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol. 2010;45:281-90
79. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141:4325-8
80. Tang-Christensen M, Vrang N, Ortmann S, et al. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology. 2004;145:4645-52
81. Druce MR, Wren AM, Park AJ, et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 2005;29:1130-6
82. Salome N, Haage D, Perrissoud D, et al. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHSR1A) antagonists in rats. Eur J Pharmacol. 2009;612:167-73
83. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A. 2004;101:4679-84
84. Zigman JM, Nakano Y, Coppari R, et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest. 2005;115:3564-72
85. Davies JS, Kotokorpi P, Eccles SR, et al. Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol. 2009;23:914-24
86. Strassburg S, Anker S, Castaneda T, et al. Long-Term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab. 2008;295:E78-84
87. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006;116:1983-93
88. Kirchner H, Gutierrez JA, Solenberg PJ, et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med. 2009;15:741-5. This study provides new insight to the ghrelin-GOAT system as a signaling pathway to indicate the presence of dietary calories, rather than their absence
89. Banks WA, Tschöp M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302:822-7
90. Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides. 2006;27:911-6
91. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002;123:1120-8
92. Sakata I, Yamazaki M, Inoue K, et al. Growth hormone secretagogue receptor expression in the cells of the stomachprojected afferent nerve in the rat nodose ganglion. Neurosci Lett. 2003;342:183-6
93. Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci. 2006;26:11052-60
94. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649-61
95. Lu S, Guan JL,Wang QP, et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett. 2002;321:157-60
96. Schwartz MW, Woods SC, Porte Jr D, et al. Central nervous system control of food intake. Nature. 2000;404:661-71
97. Guan JL, Wang QP, Kageyama H, et al. Synaptic interactions between ghrelin-and neuropeptide Y-containing neurons in the rat arcuate nucleus. Peptides. 2003;24:1921-8
98. Wang L, Saint-Pierre DH, Taché Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett. 2002;325:47-51
99. Kamegai J, Tamura H, Shimizu T, et al. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agoutirelated protein mRNA levels and body weight in rats. Diabetes. 2001;50:2438-43
100. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-8
101. Chen HY, Trumbauer ME, Chen AS, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agoutirelated protein. Endocrinology. 2004;145:2607-12
102. Chen CY, Inui A, Asakawa A, et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology. 2005;129:8-25
103. Asakawa A, Inui A, Fujimiya M, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut. 2005;54:18-24
104. Toshinai K, Yamaguchi H, Sun Y, et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology. 2006;147:2306-14
105. Inhoff T, Mönnikes H, Noetzel S, et al. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides. 2008;29:2159-68
106. ZhangW, Chai B, Li JY, et al. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology. 2008;149:4710-6
107. Ariyasu H, Takaya K, Iwakura H, et al. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology. 2005;146:355-64
108. Rodriguez A, Gomez-Ambrosi J, Catalan V, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond). 2009;33:541-52
109. Chen CY, Tsai CY, Lee WJ, et al. Intracerebroventricular O-noctanoylated ghrelin and its splice variant-induced feeding is blocked by insulin, independent of obestatin or CRF receptor, in satiated rats. Nutrition. 2012;28:812-20
110. Stengel A, Goebel M, Wang L, et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology. 2009;150:4911-9
111. Yosten GL, Samson WK. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1642-7
112. Curr Gastroenterol Rep (2012) 14:480-488
113. Atsuchi K, Asakawa A, Ushikai M, et al. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport. 2010;21:1008-11
114. Goebel M, Stengel A, Wang L, Taché Y. Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides. 2011;32:36-43
115. Gonzalez R, Kerbel B, Chun A, Unniappan S. Molecular, cellular and physiological evidences for the anorexigenic actions of nesfatin-1 in goldfish. PLoS One. 2010;5:e15201
116. Yosten GL, Samson WK. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol. 2009;297:R330-6
117. Maejima Y, Sedbazar U, Suyama S, et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009;10:355-65
118. Stengel A, Goebel-Stengel M, Wang L, et al. Nesfatin-1(30-59) but not the N-and C-Terminal fragments, nesfatin-1(1-29) and nesfatin-1(60-82) injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice. Peptides. 2012;35:143-8
119. Nonogaki K, Ohba Y, Sumii M, Oka Y. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice. Biochem Biophys Res Commun. 2008;372:186-90
120. Shimizu H, Oh-I S, Hashimoto K, et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology. 2009;150:662-71
121. Iwasaki Y, Nakabayashi H, Kakei M, et al. Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-Type channels. Biochem Biophys Res Commun. 2009;390:958-62.